You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

azacitidine

Showing 51 - 75 of 315
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Chicago (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Azacitidine
  • +5 more
  • Chicago, Illinois
    Northwestern University
Feb 16, 2023

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Canada, United States (CFI-400945, Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Duarte, California
  • +7 more
Jul 20, 2022

Relapsed/Refractory Peripheral T-cell Lymphoma Trial in Suzhou (Anti-PD-1 mAb, Lenalidomide, Azacitidine)

Recruiting
  • Relapsed/Refractory Peripheral T-cell Lymphoma
  • Anti-PD-1 monoclonal antibody
  • +2 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 21, 2021

Acute Myeloid Leukemia, MDS Trial (IMM01, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Nov 21, 2021

Acute Myeloid Leukemia Trial in United States (Tamibarotene, Venetoclax, Azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +7 more
Mar 27, 2022

Acute Myeloid Leukemia With Multilineage Dysplasia, Blasts 20-30 Percent of Bone Marrow Nucleated Cells, Blasts 20-30 Percent of

Active, not recruiting
  • Acute Myeloid Leukemia With Multilineage Dysplasia
  • +6 more
  • Azacitidine
  • Glutaminase Inhibitor CB-839
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Recruiting
  • Acute Bilineal Leukemia
  • +8 more
  • Azacitidine
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 24, 2023

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Finland (Bexmarilimab, Azacitidine, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Helsinki, Finland
  • +3 more
Jun 29, 2022

MDS, Myeloproliferative Tumors, Myelofibrosis Trial (Jaktinib, azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • (no location specified)
Nov 29, 2021

AML, MRD Trial in Shanghai (Azacitidine, Venetoclax, Selinexor)

Not yet recruiting
  • AML
  • MRD
  • Azacitidine
  • +2 more
  • Shanghai, China
  • +3 more
Feb 12, 2023

Myeloid Malignancy Trial in United States (APR-246, Venetoclax, Azacitidine)

Completed
  • Myeloid Malignancy
  • New Haven, Connecticut
  • +7 more
Jan 18, 2022

MDS Trial (Pevonedistat, Azacitidine)

No longer available
  • Myelodysplastic Syndromes
  • (no location specified)
Sep 8, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial in Worldwide (Glasdegib, Azacitidine)

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Salzburg, Austria
  • +17 more
Dec 14, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Anti-OX40 Agonist Monoclonal Antibody

Active, not recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Anti-OX40 Agonist Monoclonal Antibody PF-04518600
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 25, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Azacitidine
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

Myelodysplastic Syndrome (MDS) Trial (FF-10501-01, Azacitidine)

Withdrawn
  • Myelodysplastic Syndrome (MDS)
  • (no location specified)
Jul 20, 2021

MDS Trial in Hefei (Unrelated Umbilical Cord Blood, Venetoclax, Decetabine)

Recruiting
  • Myelodysplastic Syndromes
  • Unrelated Umbilical Cord Blood
  • +3 more
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Oct 27, 2023

Acute Myelocytic Leukemia Trial in Hefei (Unrelated umbilical cord blood, Venetoclax, Decetabine)

Recruiting
  • Acute Myelocytic Leukemia
  • Unrelated umbilical cord blood
  • +3 more
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Oct 27, 2023

Acute Myeloid Leukemia Trial (Tagraxofusp (Cycles 1-2), Azacitidine, Tagraxofusp (Cycles 3-12))

Not yet recruiting
  • Acute Myeloid Leukemia
  • Tagraxofusp (Cycles 1-2)
  • +2 more
  • (no location specified)
Jun 28, 2022

MDS, Acute Myeloid Leukemia Trial (Sabatolimab, Magrolimab, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • (no location specified)
Sep 2, 2022

MDS, Acute Myeloid Leukemia With Myelodysplasia Related Disease and < 30% Blasts, Mixed Myelodysplastic/Myeloproliferative

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Azacitidine
  • +2 more
  • Stockholm, Sweden
    Department of Hematology, Karolinska University Hospital
Mar 27, 2023

Acute Myeloid Leukemia (AML), MDS (MDS) Trial in China (APG-115, Azacitidine, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Beijing, Beijing, China
  • +13 more
Aug 16, 2022

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Tumor Trial in United States (APR-246, Azacitidine)

Completed
Has Results
  • Myelodysplastic Syndrome
  • +3 more
  • Tampa, Florida
  • +5 more
Jan 14, 2022

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Germany, United States (Emavusertib, Azacitidine, Venetoclax)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Tampa, Florida
  • +8 more
Apr 5, 2022

Acute Myeloid Leukemia Trial in Worldwide (MBG453, Venetoclax, Azacitidine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Birmingham, Alabama
  • +27 more
Jan 20, 2023